Skip to main content
Clinical Trials/NCT01626742
NCT01626742CompletedPhase 3

A Randomized Double Blinded Controlled Trial of an Oral Nutritional Supplement Containing AN 777 in Older Hospitalized Patients

Abbott Nutrition119 sites in 1 country652 target enrollmentStarted: May 1, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
652
Locations
119
Primary Endpoint
Return to hospital or death

Study Overview

Brief Summary

Evaluate effects of an oral nutritional supplement on healthcare outcomes in older hospitalized adults. Also referred to as the NOURISH Study - Nutrition effect On Unplanned Readmissions and Survival in Hospitalized patients.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
65 Years to — (Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Male or female ≥ 65 years of age.
  • •Admitted to hospital with diagnosis of heart failure, acute myocardial infarction, pneumonia, or chronic obstructive pulmonary disease.
  • •Subjective Global Assessment rating of B or C.
  • •Length of hospital stay anticipated to be > 3 days and < 12 days
  • •Able to consume foods and beverages orally.
  • •Functionally ambulatory during the 30 days prior to admission.

Exclusion Criteria

  • •Uncontrolled hypertension
  • •Diagnosis of diabetes
  • •Current active cancer or recently treated cancer
  • •Impaired renal function
  • •Liver failure, acute Hepatitis, or hepatic encephalopathy
  • •Active tuberculosis.
  • •Disorder of gastrointestinal tract
  • •Autoimmune disorder
  • •Intubation, and/or tube or parenteral feeding.
  • •Severe dementia or delirium, brain metastases, eating disorder, history of significant neurological or psychiatric disorder, alcoholism, substance abuse or other conditions that may interfere with study product consumption or compliance with study protocol procedures
  • •Allergy or intolerance to any of the ingredients in the study products.
  • •Body mass index of ≥ 40 kg/m
  • •Resident in a nursing home or other residential facility.
  • •Planned surgery during course of the study.

Arms & Interventions

Ready to drink flavored beverage

Placebo Comparator

Intervention: Ready to Drink Flavored Beverage (Other)

Ready to drink flavored beverage w/ AN 777

Experimental

Intervention: Ready to drink flavored beverage w/ AN 777 (Other)

Outcomes

Primary Outcomes

Return to hospital or death

Time Frame: 90 days

Secondary Outcomes

  • Return to hospital or death(30 and 60 days)
  • Hospital Days(90 days)
  • Activities of Daily Living(90 days)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (119)

Loading locations...

Similar Trials